CLINICAL_TRIALS
trial_result
· 2017-01-06
Clinical Trial Update: Angiosome Perfusion After Tibial Bypass [Phase 2]
Summary
Phase 2 clinical trial evaluating angiosome-directed perfusion after tibial bypass for peripheral arterial disease has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University Hospital Erlangen | Conditions: Peripheral Arterial Disease | Phase 2 | Status: COMPLETED